Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/9913
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Intranasal steroids and the risk of emergency department visits for asthma
Author: Adams, R.
Fuhlbrigge, A.
Finkelstein, J.
Weiss, S.
Citation: Journal of Allergy and Clinical Immunology, 2002; 109(4):636-642
Publisher: Mosby Inc
Issue Date: 2002
ISSN: 0091-6749
1097-6825
Statement of
Responsibility: 
Robert J. Adams, Anne L. Fuhlbrigge, Jonathan A. Finkelstein and Scott T. Weiss
Abstract: BACKGROUND: In patients with asthma, treatment for associated conditions, such as rhinitis, is recommended. It is unknown whether this treatment can reduce the risk for emergency department (ED) visits for asthma. OBJECTIVES: We sought to determine whether treatment with intranasal steroids or prescription antihistamines in persons with asthma is associated with a reduced risk for ED visits caused by asthma. METHODS: We performed a retrospective cohort study of members of a managed care organization aged greater than 5 years who were identified during the period of October 1991 to September 1994 as having a diagnosis of asthma by using a computerized medical record system. The main outcome measure was an ED visit for asthma. RESULTS: Of the 13,844 eligible persons, 1031 (7.4%) had an ED visit for asthma. The overall relative risk (RR) for an ED visit among those who received intranasal corticosteroids, adjusted for age, sex, frequency of orally inhaled corticosteroid and β-agonist dispensing, amount and type of ambulatory care for asthma, and diagnosis of an upper airways condition (rhinitis, sinusitis, or otitis media), was 0.7 (95% confidence interval [CI], 0.59-0.94). For those receiving prescription antihistamines, the risk was indeterminate (RR, 0.9; 95% CI, 0.78-1.11). When different rates of dispensing for intranasal steroids were examined, a reduced risk was seen in ED visits in those with greater than 0 to 1 (RR, 0.7; 95% CI, 0.57-0.99) and greater than 3 (RR, 0.5; 95% CI, 0.23-1.05) dispensed prescriptions per year. CONCLUSIONS: Treatment of nasal conditions, particularly with intranasal steroids, confers significant protection against exacerbations of asthma leading to ED visits for asthma. These results support the use of intranasal steroids by individuals with asthma and upper airways conditions.
Keywords: Asthma; Rhinitis; therapeutics; outcome assessment
Description: Copyright © 2002 Mosby, Inc. All rights reserved.
RMID: 0020020538
DOI: 10.1067/mai.2002.123237
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.